CMO Walid Abi-Saab exercises shares and sells 45,000 shares for ~$1.1M net, reducing stake by 10.5% as stock trades well below 52-week highs.
Walid Abi-Saab, Chief Medical Officer, exercised 25,000 shares and immediately sold 45,000 shares on the same day for a combined ~$1.1M, reducing his holdings by roughly one-tenth. This is his 6th and 7th open-market sale in the past three years—his pattern is consistently disposing shares when opportunities arise, with no open-market purchases in the same window. The sales themselves are not dramatic given the company's financial picture: uniQure is unprofitable with recent revenue declining sharply and net losses continuing to mount. The stock trades significantly below its 52-week high, having declined from the upper range over recent months. While a single executive selling during a period of financial strain is not unusual, the pattern of consistent dispositions—particularly a c-suite sale exceeding $1.1M in a single trading session—warrants attention to whether other officers or directors are also reducing exposure or whether this reflects normal equity management by a long-tenured medical officer with accumulated shares from compensation.